MoneyWorks4Me

Dishman Pharmaceuticals’ arm receives EIR for two units

14 Jul 2016 Evaluate

Carbogen Amcis AG, a Switzerland based wholly owned subsidiary of Dishman Pharmaceuticals and Chemicals had successfully completed USFDA inspection for its two sites located at Aarau and Neuland without any adverse observations and received the Establishment inspection Report (ElR) for the same. Thus, now the company has the above two sites in addition to Bubendorf in Switzerland, which are approved by the USFDA. Additionally, the company's site at Naroda had also successfully completed USFDA inspection and received the Establishment Inspection Report (ElR) for the same.

Dishman Pharmaceuticals and Chemicals is a global outsourcing partner for the pharmaceutical industry, offering a portfolio of development, scale-up and manufacturing services. It improves its customers’ businesses by providing a range of development and manufacturing solutions at locations in Europe and in India.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..